Acute/relapsing experimental autoimmune encephalomyelitis: Induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Multiple Sclerosis

• Publication date

  1999-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/135245859900500104PMID 10096098
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis

  1997cited by this paper
• New concepts in tolerance

  1996cited by this paper
• Treatment of relapsing experimental autoimmune encephalomyelitis with largely MHC-matched allogeneic bone marrow transplantation.

  1996cited by this paper
• Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation.

  1996cited by this paper
• Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation.

  1996cited by this paper
• Bone marrow transplantation for multiple sclerosis.

  1995cited by this paper
• Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis

  1995cited by this paper
• Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT)

  1995cited by this paper
• Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain.

  1995cited by this paper
• Immune Ablation with Stem-Cell Rescue: A Possible Cure for Systemic Lupus Erythematosus?

  1993cited by this paper
• Immunohematopoietic reconstitution by allogeneic and autologous bone marrow grafts as a means for induction of specific unresponsiveness to donor-specific allografts and modified self in autoimmune disorders.

  1993cited by this paper
• Apparent cure of rheumatoid arthritis by bone marrow transplantation.

  1993cited by this paper
• Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT.

  1993cited by this paper
• Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.

  1993cited by this paper
• Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation.

  1992cited by this paper
• Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation.

  1992cited by this paper
• Studies on the refractoriness to reinduction of experimental allergic encephalomyelitis in Lewis rats that have recovered from one episode of the disease.

  1990cited by this paper
• MS: a CNS and systemic autoimmune disease.

  1989cited by this paper
• Autologous blood stem cell transplantation.

  1989cited by this paper
• Overview of the rationale for immunomodulating therapies in multiple sclerosis

  1988cited by this paper
• Clinical and genetic investigation in autosomal dominant limb‐girdle muscular dystrophy

  1988cited by this paper
• Marrow transplantation from tolerant donors to treat and prevent autoimmune diseases in BXSB mice.

  1988cited by this paper
• Clinical experience with azathioprine: The pros

  1988cited by this paper
• Cyclosporine and multiple sclerosis: The cons

  1988cited by this paper
• Effect of total lymphoid irradiation in chronic progressive multiple sclerosis.

  1986cited by this paper
• Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation.

  1985cited by this paper
• Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.

  1984cited by this paper
• Detection of autoimmune cells proliferating to myelin basic protein and selection of T cell lines that mediate experimental autoimmune encephalomyelitis (EAE) in mice.

  1983cited by this paper
• Role of the thymus in murine lupus and cellular transfer of the disease.

  1982cited by this paper
• Spontaneous remission of autoimmune encephalomyelitis is inhibited by splenectomy, thymectomy or ageing

  1980cited by this paper
• Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice.

  1980cited by this paper
• Transplantation of autoimmune potential. IV. Reversal of the NZB autoimmune syndrome by bone marrow transplantation.

  1979cited by this paper
• Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction.

  1979cited by this paper
• [Influence of cyclophosphamide on the production of experimentale autoimmune encephalomyelitis (author's transl)].

  1978cited by this paper
• ACETYLCHOLINE-RECEPTOR-BLOCKING FACTOR AND STRIATED-MUSCLE ANTIBODY IN MYASTHENIA GRAVIS

  1976cited by this paper
• Experimental autoimmune encephalomyelitis in mice: immunologic response to mouse spinal cord and myelin basic proteins.

  1975cited by this paper
• Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species.

  1972cited by this paper
• Chemotherapy of experimental allergic encephalomyelitis (EAE).

  1969cited by this paper

• Advances in hematopoietic stem cell transplantation for autoimmune diseases

  2024cites this paper
• The preclinical data and immunologic rationale for hematopoietic stem cell transplantation in autoimmunity.

  2024cites this paper
• Vaccines and Optic Neuritis: Consequence or Coincidence?

  2021cites this paper
• Bone Marrow Transfer in Relapsing-Remitting EAE Ameliorates Disease at First Remission, with No Synergistic Effect upon Co-Transplantation with Mesenchymal Stem Cells

  2021cites this paper
• Post Transplantation Cyclophosphamide Improves Outcome of Autologous Hematopoietic Stem Cell Transplantation in Animal Model of Multiple Sclerosis

  2021cites this paper
• Species differences in immune‐mediated CNS tissue injury and repair: A (neuro)inflammatory topic

  2019cites this paper
• A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future

  2018cites this paper
• Immune reconstitution therapy (IRT) in multiple sclerosis: the rationale

  2018cites this paper
• The future of MS Treatments

  2016cites this paper
• Stem Cells in Multiple Sclerosis

  2016cites this paper
• The future of multiple sclerosis treatments

  2016cites this paper
• Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party

  2015cites this paper
• Vaccines, adjuvants and autoimmunity

  2015cites this paper
• Current Approaches and Future Prospects for the Prevention of β-Cell Destruction in Autoimmune Diabetes

  2015cites this paper
• Induction of tolerance and prolongation of islet allograft survival by syngeneic hematopoietic stem cell transplantation in mice.

  2015cites this paper
• Acute Disseminated Encephalomyelitis: Idiopathic, Post‐infectious, and Post‐vaccination

  2015cites this paper
• The spectrum of post-vaccination inflammatory CNS demyelinating syndromes.

  2014cites this paper
• Hematopoietic stem cell transplantation in multiple sclerosis

  2013cites this paper
• Stem Cell-based Therapies in Multiple Sclerosis

  2013cites this paper
• Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)

  2011cites this paper
• Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results

  2011cites this paper
• Treatment of an autoimmune encephalomyelitis mouse model with nonmyeloablative conditioning and syngeneic bone marrow transplantation

  2011influential citation
• A Preliminary Result of Treatment of Neuromyelitis Optica With Autologous Peripheral Hematopoietic Stem Cell Transplantation

  2010cites this paper
• Autologous and allogeneic hematopoietic stem cell transplantation for Multiple Sclerosis: perspective on mechanisms of action.

  2008cites this paper
• A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.

  2008cites this paper
• The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience.

  2008cites this paper
• Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome

  2008cites this paper
• Cytokines in Demyelinating Diseases

  2008cites this paper
• Use of stem cells for the treatment of multiple sclerosis

  2007cites this paper
• Bone marrow transplantation: does it stop MS progression?

  2007cites this paper
• Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a graft-versus-autoimmunity effect.

  2007cites this paper
• T-lymphocyte reconstitution following rigorously T-cell-depleted versus unmodified autologous stem cell transplants

  2006cites this paper
• Tolerance induction by bone marrow transplantation in a multiple sclerosis model.

  2005cites this paper
• Aggressive multiple sclerosis—is there a role for stem cell transplantation?

  2005cites this paper
• Immunoablative therapy as a treatment aggressive multiple sclerosis.

  2005cites this paper
• Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience.

  2004cites this paper
• Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures

  2004cites this paper
• Stem cell transplantation for autoimmune disorders. Multiple sclerosis.

  2004cites this paper
• High-Dose Immunosuppression and Autologous Hematopoietic Stem Cell Rescue for Severe Multiple Sclerosis

  2003cites this paper
• Stem cell transplantation for multiple sclerosis: what is the evidence?

  2003cites this paper
• Intense immunosuppression and autologous hematopoietic stem cell transplantation for multiple sclerosis.

  2003cites this paper
• High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

  2003influential citation
• Chronic graft versus host disease after allogeneic peripheral blood transplantation.

  2003cites this paper
• Chronic graft versus host disease after allogeneic peripheral blood transplantation.

  2003cites this paper
• Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure?

  2002cites this paper
• Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells.

  2002cites this paper
• The myelin basic protein gene is expressed in differentiated blood cell lineages and in hemopoietic progenitors

  2002cites this paper
• Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis

  2002cites this paper
• Hematopoietic stem cell therapy for type 1 diabetes: induction of tolerance and islet cell neogenesis.

  2002cites this paper
• Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?

  2002cites this paper
• Bone Marrow Cell Graft Engineering: From Bench to Bedside

  2001cites this paper
• Immunologic therapy for secondary and primary progressive multiple sclerosis

  2001cites this paper
• Bone marrow cells inhibit the generation of autologous EBV-specific CTL.

  2000cites this paper